Prognostic implications of biopsy with tumour transection for high-risk primary melanoma patients
Authorsvon Schuckmann, LA
Van der Pols, JC
Green, Adèle C
AffiliationPopulation Health Department, QIMR Berghofer Medical Research Institute, Australia
MetadataShow full item record
Citationvon Schuckmann LA, Khosrotehrani K, Celia BHM, van der Pols JC, Malt M, Smithers BM, et al. Prognostic implications of biopsy with tumour transection for high-risk primary melanoma patients. J Am Acad Dermatol. 2020.
JournalJournal of the American Academy of Dermatology
- Clinical and pathologic factors associated with deep transection of biopsies of invasive melanoma.
- Authors: Woodcock JL, Eyre ZW, Stoddard GJ, Callis Duffin K, Bowen AR
- Issue date: 2017 Oct
- The rate of melanoma transection with various biopsy techniques and the influence of tumor transection on patient survival.
- Authors: Mir M, Chan CS, Khan F, Krishnan B, Orengo I, Rosen T
- Issue date: 2013 Mar
- Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
- Authors: Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR
- Issue date: 2010 Mar 15
- Prognostic factors.
- Authors: Rogers GS, Braun SM
- Issue date: 2002 Oct
- Residual melanoma after an excisional biopsy is an independent prognostic factor for local recurrence and overall survival.
- Authors: Hocevar M, Dragonja Z, Pilko G, Gazic B, Zgajnar J
- Issue date: 2014 Oct